A.N. v. HHS - Tdap, Guillain-Barré Syndrome (GBS) (2018)

On October 11, 2016, Cheryl and David Nicosia, parents of A.N., a minor, filed a petition for vaccine compensation. They alleged that A.N. received tetanus-diphtheria-acellular pertussis (Tdap) and meningococcal conjugate (MCV) vaccines on September 15, 2014, which caused the child to develop Guillain-Barré Syndrome (GBS).

The parties, represented by Edward M. Kraus for the petitioners and Ann D.

Martin for the respondent, filed a stipulation for award on February 27, 2018. The respondent denied that the vaccines caused A.N.'s GBS but agreed to a settlement.

Special Master Herbrina Sanders reviewed the stipulation and found it reasonable. The stipulation awarded A.N. $7,500.00 for past unreimbursable expenses, payable to Cheryl and David Nicosia, and $98,000.00 for A.N.'s estate, payable to petitioners as guardians/conservators.

The total award was $105,500.00. The decision was entered on February 28, 2018, consistent with the stipulation.

The case was brought as a Table claim, as GBS is listed on the Vaccine Injury Table for the Tdap vaccine. The public decision does not describe the specific onset, symptoms, medical tests, treatments, or the mechanism of causation.